Québec City, September 23, 2019 – Pharma in silica inc. announces today the addition of mister Bertrand Bolduc, pharmacist and experienced entrepreneur to its board of directors. He joins the directors François Arcand (Pharma in silica), Michel L’Heureux (Valro), Mathieu Poirier (Pfizer), Hugo St-Laurent (SiliCycle) and Guillaume Thivierge (Clean Technologies).

« Bertrand brings to Pharma in silica his sagacity, his deep knowledge of therapeutic actives and his expertise in life sciences: corporate governance, regulatory pathways, good manufacturing practices and business strategies », stated François Arcand, the young enterprise’s president.

Pharma in silica is a preclinical stage company based in Québec City’s Parc Technologique. It develops a novel drug nanocarrier made of minute silica spheres. The company intends to reduce the toxicity and increase the efficacy of chemotherapy drugs.

For more details
François Arcand
President, Pharma in silica inc.
+1 418 874-0054 #233
arcandf@pharma-insilica.com